Prognosis of patients hospitalized with a diagnosis of COVID-19 pneumonia in a tertiary hospital in Turkey.
Ann Saudi Med
; 41(6): 327-335, 2021.
Article
in English
| MEDLINE | ID: covidwho-1555174
ABSTRACT
BACKGROUND:
SARS-CoV2/COVID-19 emerged in China and caused a global pandemic in 2020. The mortality rate has been reported to be between 0% and 14.6% in all patients. In this study, we determined the clinical and laboratory parameters of COVID-19 related morbidity and mortality in our hospital.OBJECTIVES:
Investigate the relationship between demographic, clinical, and laboratory parameters on COVID-19-related morbidity and mortality.DESIGN:
Retrospective observational study. SETTINGS Tertiary care hospital. PATIENTS ANDMETHODS:
Patients diagnosed with COVID-19 pneumonia from March until the end of December were included in the study. MAIN OUTCOMEMEASURES:
The relationship between demographic, clinical, and laboratory parameters and the morbidity and mortality rates of patients diagnosed with COVID-19. SAMPLE SIZE 124 patientsRESULTS:
The mortality rate was 9.6% (12/124). Coronary artery disease (P<.0001) diabetes mellitus (P=.04) fever (>38.3°C) at presentation (P=.04) hypertension (P<.0001), and positive smoking history (P<.0001) were significantly associated with mortality. Patients who died were older, had a higher comorbid disease index, pneumonia severity index, fasting blood glucose, baseline serum creatinine, D-dimer, and had lower baseline haemoglobin, SaO2, percentage of lymphocyte counts and diastolic blood pressure. Patients admitted to the ICU were older, had a higher comorbidity disease index, pneumonia severity index, C-reactive protein, WBC, D-dimer, creatinine, number of antibiotics used, longer O2 support duration, lower hemoglobin, lymphocyte (%), and baseline SaO2 (%).CONCLUSIONS:
Our results were consistent with much of the reported data. We suggest that the frequency, dosage, and duration of steroid treatment should be limited.LIMITATIONS:
Low patient number, uncertain reason of mortality, no standard treatment regimen, limited treatment options, like ECMO. CONFLICT OF INTEREST None.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia
/
COVID-19
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Ann Saudi Med
Journal subject:
Medicine
Year:
2021
Document Type:
Article
Affiliation country:
0256-4947.2021.327
Similar
MEDLINE
...
LILACS
LIS